Your browser doesn't support javascript.
loading
Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.
Sankaranarayanan, Rengaswamy; Basu, Partha; Kaur, Prabhdeep; Bhaskar, Rajesh; Singh, Gurinder Bir; Denzongpa, Phumzay; Grover, Rajesh K; Sebastian, Paul; Saikia, Tapan; Oswal, Kunal; Kanodia, Rishav; Dsouza, Amantia; Mehrotra, Ravi; Rath, Goura Kishor; Jaggi, Viniita; Kashyap, Sundram; Kataria, Ishu; Hariprasad, Roopa; Sasieni, Peter; Bhatla, Neerja; Rajaraman, Preetha; Trimble, Edward L; Swaminathan, Soumya; Purushotham, Arnie.
Afiliación
  • Sankaranarayanan R; RTI International India, New Delhi, India; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Basu P; International Agency for Research on Cancer, World Health Organization, Lyon, France. Electronic address: basup@iarc.fr.
  • Kaur P; National Institute of Epidemiology, Indian Council of Medical Research, Chennai, India.
  • Bhaskar R; Department of Health and Family Welfare, Government of Punjab, Chandigarh, India.
  • Singh GB; Department of Health and Family Welfare, Government of Punjab, Chandigarh, India.
  • Denzongpa P; Human Services and Family Welfare Department, Government of Sikkim, Gangtok, India.
  • Grover RK; Delhi State Cancer Institute, Delhi, India.
  • Sebastian P; Tata Trusts, Mumbai, India.
  • Saikia T; Prince Aly Khan Hospital, Mumbai, India.
  • Oswal K; Tata Trusts, Mumbai, India.
  • Kanodia R; Tata Trusts, Mumbai, India.
  • Dsouza A; Tata Trusts, Mumbai, India.
  • Mehrotra R; National Institute of Cancer Prevention and Research, Indian Council of Medical Research, Noida, India.
  • Rath GK; National Cancer Institute, All India Institute of Medical Sciences, Jhajjar Campus, Badsa, Haryana, India; Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
  • Jaggi V; Delhi State Cancer Institute, Delhi, India.
  • Kashyap S; Delhi State Cancer Institute, Delhi, India.
  • Kataria I; RTI International India, New Delhi, India.
  • Hariprasad R; National Institute of Cancer Prevention and Research, Indian Council of Medical Research, Noida, India.
  • Sasieni P; Kings Clinical Trials Unit, King's College London, London, UK.
  • Bhatla N; Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Rajaraman P; Office of Global Affairs, Department of Health and Human Services, Washington, DC, USA.
  • Trimble EL; Global HPV and Cervical Cancer Research and Control, National Cancer Institute, Rockville, MD, USA.
  • Swaminathan S; World Health Organization, Geneva, Switzerland.
  • Purushotham A; King's Health Partners Integrated Cancer Centre, King's College London, London, UK.
Lancet Oncol ; 20(11): e637-e644, 2019 11.
Article en En | MEDLINE | ID: mdl-31674322

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Vacunación / Programas de Inmunización / Infecciones por Papillomavirus / Vacunas contra Papillomavirus / Erradicación de la Enfermedad Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Vacunación / Programas de Inmunización / Infecciones por Papillomavirus / Vacunas contra Papillomavirus / Erradicación de la Enfermedad Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia